Cleaved high molecular weight kininogen, a novel factor in the regulation of matrix metalloproteinases in vascular smooth muscle cells

Biochemical Pharmacology

Volumn 79, Issue 2, 2010, Pages 172-179

  Vosgerau, Uwe ^a   Lauer, Diljara ^a   Unger, Thomas ^a   Kaschina, Elena ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Kininogen; Matrix metalloproteinases; Smooth muscle cells; Tissue inhibitors of MMPs; Vascular biology

Indexed keywords

FLUORESCEIN; GELATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1ALPHA; KININOGEN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; AORTA MEDIA; ARTICLE; BROWN NORWAY RAT; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME RELEASE; FLUORESCENCE ANALYSIS; GENE EXPRESSION REGULATION; IN VITRO STUDY; MALE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA DEGRADATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ZYMOGRAPHY;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; KININOGENS; MATRIX METALLOPROTEINASES; MOLECULAR WEIGHT; MUSCLE, SMOOTH, VASCULAR; POLYMERASE CHAIN REACTION; RATS;

EID: 71749105266     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.08.004     Document Type: Article

References (31)

1. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.F., and Newby A.C. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 315 Pt 1 (1996) 335-342
2. McMillan W.D., Patterson B.K., Keen R.R., and Pearce W.H. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg 22 (1995) 295-305
3. Davis V., Persidskaia R., Baca-Regen L., Itoh Y., Nagase H., Persidsky Y., et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 18 (1998) 1625-1633
4. Kadoglou N.P., and Liapis C.D. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin 20 (2004) 419-432
5. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., and Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15 (1995) 1145-1151
6. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., and Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 (2002) 625-632
7. Kaschina E., Stoll M., Sommerfeld M., Steckelings U.M., Kreutz R., and Unger T. Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis. Physiol Genomics 19 (2004) 41-49
8. Hayashi I., and Oh-ishi S. Plasma kininogen deficiency: associated defective secretion of kininogens by primary cultures of hepatocytes from brown Norway Katholiek rats. J Biochem 113 (1993) 531-537
9. Weisel J.W., Nagaswami C., Woodhead J.L., DeLa Cadena R.A., Page J.D., and Colman R.W. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. J Biol Chem 269 (1994) 10100-10106
10. Zhang J.C., Claffey K., Sakthivel R., Darzynkiewicz Z., Shaw D.E., Leal J., et al. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. Faseb J. 14 (2000) 2589-2600
11. Colman R.W., Jameson B.A., Lin Y., Johnson D., and Mousa S.A. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood 95 (2000) 543-550
12. Campbell J.H., and Campbell G.R. Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci (Lond) 85 (1993) 501-513
13. Schefe J.H., Lehmann K.E., Buschmann I.R., Unger T., and Funke-Kaiser H. Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med 84 (2006) 901-910
14. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Unemori E.N., Lark M.W., et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75 (1994) 181-189
15. Chase A.J., and Newby A.C. Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling. J Vasc Res 40 (2003) 329-343
16. Middleton R.K., Lloyd G.M., Bown M.J., Cooper N.J., London N.J., and Sayers R.D. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J Vasc Surg 25 (2007) 574-580
17. McMillan W.D., and Pearce W.H. Inflammation and cytokine signaling in aneurysms. Ann Vasc Surg 11 (1997) 540-545
18. Eberhardt W., Akool el S., Rebhan J., Frank S., Beck K.F., Franzen R., et al. Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor alpha agonists is indirect and due to a NO-mediated reduction of mRNA stability. J Biol Chem 277 (2002) 33518-33528
19. Akool el S., Kleinert H., Hamada F.M., Abdelwahab M.H., Forstermann U., Pfeilschifter J., et al. Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol Cell Biol 23 (2003) 4901-4916
20. Curry Jr. T.E., and Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 24 (2003) 428-465
21. Klein G., Vellenga E., Fraaije M.W., Kamps W.A., and de Bont E.S.J.M. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukaemia. Crit Rev Onkol/Hematol 50 (2004) 87-100
22. Tamarina N.A., McMillan W.D., Shively V.P., and Pearce W.H. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 122 (1997) [discussion 271-262]
23. Thompson R.W., Holmes D.R., Mertens R.A., Liao S., Botney M.D., Mecham R.P., et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 96 (1995) 318-326
24. Butler G.S., Butler M.J., Atkinson S.J., Will H., Tamura T., Schade van Westrum S., et al. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273 (1998) 871-880
25. Xiong W., Knispel R., Mactaggart J., and Baxter B.T. Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation. J Vasc Surg 44 (2006) 1061-1066
26. Crowther M., Goodall S., Jones J.L., Bell P.R., and Thompson M.M. Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. J Vasc Surg 32 (2000) 575-583
27. Cao D.J., Guo Y.L., and Colman R.W. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells. Circ Res 94 (2004) 1227-1234
28. Zhang J.C., Donate F., Qi X., Ziats N.P., Juarez J.C., Mazar A.P., et al. The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin. Proc Natl Acad Sci U S A 99 (2002) 12224-12229
29. Herwald H., Dedio J., Kellner R., Loos M., and Muller-Esterl W. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J Biol Chem 271 (1996) 13040-13047
30. Hasan A.A., Zisman T., and Schmaier A.H. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Proc Natl Acad Sci U S A 95 (1998) 3615-4362
31. Dumler I., Weis A., Mayboroda O.A., Maasch C., Jerke U., Haller H., et al. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 273 (1998) 315-321